Sakamoto J - Search Results

1

Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.

Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Nozaki I, Kojima H, Miyashita Y, Oba K, Buyse M, Morita S, Sakamoto J. Tsuburaya A, et al. Among authors: sakamoto j. Lancet Oncol. 2014 Jul;15(8):886-93. doi: 10.1016/S1470-2045(14)70025-7. Epub 2014 Jun 18. Lancet Oncol. 2014. PMID: 24954805 Clinical Trial.

2

Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials.

Sakamoto J, Teramukai S, Nakazato H, Sato Y, Uchino J, Taguchi T, Ryoma Y, Ohashi Y. Sakamoto J, et al. J Immunother. 2002 Sep-Oct;25(5):405-12. doi: 10.1097/00002371-200209000-00004. J Immunother. 2002. PMID: 12218778

3

Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial.

Sakamoto J, Hamashima H, Suzuki H, Ito K, Mai M, Saji S, Fukushima M, Matsushita Y, Nakazato H. Sakamoto J, et al. Oncol Rep. 2003 Sep-Oct;10(5):1081-90. Oncol Rep. 2003. PMID: 12883662 Clinical Trial.

4

Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.

Morita S, Kobayashi K, Eguchi K, Matsumoto T, Shibuya M, Yamaji Y, Sakamoto J, Ohashi Y. Morita S, et al. Among authors: sakamoto j. Jpn J Clin Oncol. 2003 Sep;33(9):470-6. doi: 10.1093/jjco/hyg083. Jpn J Clin Oncol. 2003. PMID: 14594941 Clinical Trial.

5

[Effective use of combination chemotherapy with paclitaxel and 5-fluorouracil in a case of non-resectable advanced gastric cancer].

Inagaki H, Kojima H, Kato J, Kojima T, Fujimitsu Y, Matsui T, Miyashita Y, Sakamoto J. Inagaki H, et al. Among authors: sakamoto j. Gan To Kagaku Ryoho. 2003 Nov;30(12):1983-7. Gan To Kagaku Ryoho. 2003. PMID: 14650972 Japanese.

6

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.

Fukui T, Rahman M, Hayashi K, Takeda K, Higaki J, Sato T, Fukushima M, Sakamoto J, Morita S, Ogihara T, Fukiyama K, Fujishima M, Saruta T; CASE-J Study Group. Fukui T, et al. Among authors: sakamoto j. Hypertens Res. 2003 Dec;26(12):979-90. doi: 10.1291/hypres.26.979. Hypertens Res. 2003. PMID: 14717341 Free article. Review.

7

Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials.

Sakamoto J, Ohashi Y, Hamada C, Buyse M, Burzykowski T, Piedbois P; Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum; Meta-Analysis Group in Cancer. Sakamoto J, et al. J Clin Oncol. 2004 Feb 1;22(3):484-92. doi: 10.1200/JCO.2004.04.065. J Clin Oncol. 2004. PMID: 14752071

8

Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer.

Morita S, Toi M, Kobayashi T, Ito Y, Hozumi Y, Ohno S, Iwata H, Sakamoto J. Morita S, et al. Among authors: sakamoto j. Jpn J Clin Oncol. 2004 Feb;34(2):104-6. doi: 10.1093/jjco/hyh016. Jpn J Clin Oncol. 2004. PMID: 15067105 Clinical Trial.

9

Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy.

Morita S, Ohashi Y, Hirakawa K, Nakata B, Saji S, Sakamoto J. Morita S, et al. Among authors: sakamoto j. Jpn J Clin Oncol. 2004 Mar;34(3):159-61. doi: 10.1093/jjco/hyh031. Jpn J Clin Oncol. 2004. PMID: 15078913 Clinical Trial.

10

[Planning, administration, and management of the clinical trial based on EBM -what are key points to generate valid evidence?].

Sakamoto J, Morita S. Sakamoto J, et al. Arerugi. 2004 Apr;53(4):413-6. Arerugi. 2004. PMID: 15187485 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,155 results

Search Page

Filters